StonvexLoading…
StonvexStonvexStonvexCore line items from NMIH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $706.44M | $650.97M | $579.00M | $523.35M |
Operating Income | $499.80M | $463.41M | $412.70M | $377.31M |
Net Income | $388.93M | $360.11M | $322.11M | $292.90M |
EPS (Diluted) | $4.92 | $4.43 | $3.84 | $3.39 |
Total Assets | $3.84B | $3.35B | $2.94B | $2.52B |
Total Liabilities | $1.25B | $1.13B | $1.01B | $902.30M |
Cash & Equivalents | $43.94M | $54.31M | $96.69M | $44.43M |
Free Cash Flow OCF − CapEx | $412.52M | $386.70M | $333.31M | $302.82M |
Shares Outstanding | 76.29M | 78.60M | 80.88M | 83.55M |